title: Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors.
abstract: Binding specificity between fibroblast growth factors (FGFs) and their receptors (FGFRs) is essential for mammalian development and is regulated primarily by two alternatively spliced exons, IIIb ("b") and IIIc ("c"), that encode the second half of Ig-like domain 3 (D3) of FGFRs. FGF7 and FGF10 activate only the b isoform of FGFR2 (FGFR2b). Here, we report the crystal structure of the ligand-binding portion of FGFR2b bound to FGF10. Unique contacts between divergent regions in FGF10 and two b-specific loops in D3 reveal the structural basis by which alternative splicing provides FGF10-FGFR2b specificity. Structure-based mutagenesis of FGF10 confirms the importance of the observed contacts for FGF10 biological activity. Interestingly, FGF10 binding induces a previously unobserved rotation of receptor Ig domain 2 (D2) to introduce specific contacts with FGF10. Hence, both D2 and D3 of FGFR2b contribute to the exceptional specificity between FGF10 and FGFR2b. We propose that ligand-induced conformational change in FGFRs may also play an important role in determining specificity for other FGF-FGFR complexes.
authors.affiliation: Department of Pharmacology, New York University School of Medicine, New York, NY 10016, USA.
authors.forename: Brian K
authors.initials: BK
authors.lastname: Yeh
authors.forename: Makoto
authors.initials: M
authors.lastname: Igarashi
authors.forename: Anna V
authors.initials: AV
authors.lastname: Eliseenkova
authors.forename: Alexander N
authors.initials: AN
authors.lastname: Plotnikov
authors.forename: Ifat
authors.initials: I
authors.lastname: Sher
authors.forename: Dina
authors.initials: D
authors.lastname: Ron
authors.forename: Stuart A
authors.initials: SA
authors.lastname: Aaronson
authors.forename: Moosa
authors.initials: M
authors.lastname: Mohammadi
mesh_terms: D017398:Alternative Splicing; D000595:Amino Acid Sequence; D018360:Crystallography, X-Ray; D004247:DNA / Q000378:metabolism; D005091:Exons; D051526:Fibroblast Growth Factor 10; D005346:Fibroblast Growth Factors / Q000378:metabolism; D006801:Humans; D006860:Hydrogen Bonding; D008024:Ligands; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D011485:Protein Binding; D011487:Protein Conformation; D020033:Protein Isoforms; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D051497:Receptor, Fibroblast Growth Factor, Type 2; D017468:Receptors, Fibroblast Growth Factor / Q000737:chemistry* / Q000378:metabolism; D012645:Selenomethionine / Q000737:chemistry; D017386:Sequence Homology, Amino Acid; D013329:Structure-Activity Relationship; D014018:Tissue Distribution
chemical_list: C496463:FGF10 protein, human; D051526:Fibroblast Growth Factor 10; D008024:Ligands; D020033:Protein Isoforms; D017468:Receptors, Fibroblast Growth Factor; D005346:Fibroblast Growth Factors; D004247:DNA; D012645:Selenomethionine; D051497:Receptor, Fibroblast Growth Factor, Type 2